Key Takeaways
- • Blackstone (BX) shares rose 3.24% on October 15, 2026, with intraday volatility, according to TradingKey, driven mainly by deal realization news and positioning ahead of third-quarter earnings.
- • Blackstone Tactical Opportunities agreed to sell portfolio company ZO Skin Health to Swiss dermatology group Galderma for a $1.5 billion cash exit, a monetization that supports performance-fee generation.
- • Analysts at UBS, Bank of America and TD Cowen have lowered BX price targets, warning that third-quarter asset realizations and fee-related earnings are tracking below consensus.
- • Blackstone postponed a planned $1.5 billion Singapore REIT IPO for its AirTrunk data center unit until 2027, removing a near-term monetization catalyst.
- • Q3 2026 earnings are scheduled for October 22, with consensus at $1.31 EPS and $3.36 billion revenue.
Summary
Investor interest was also reinforced by coverage of Blackstone's digital infrastructure expansion, including its buildout of a $200 billion data center platform, along with private credit origination and energy infrastructure activity. The source cited a leading role in a $1 billion financing earlier in the week as evidence of deployment momentum across yield-focused platforms.
The article characterized the price rebound as reflecting institutional positioning ahead of the third-quarter earnings release. It noted that the stock trades at compressed valuation multiples relative to its historical averages. Consensus expectations for Q3, scheduled for October 22, point to $1.31 EPS and $3.36 billion in revenue, per the publisher's data.
The move comes against a more cautious backdrop. Wall Street firms including UBS, Bank of America and TD Cowen have recently cut target prices, citing warnings that third-quarter realizations and fee-related earnings are tracking below consensus. Blackstone's decision to postpone the planned $1.5 billion Singapore REIT IPO for AirTrunk until 2027 removes a significant near-term monetization catalyst. Other risks flagged include AI infrastructure buildout friction, and elevated Treasury yields that raise borrowing costs, pressure commercial real estate valuations and drive redemptions in retail private credit vehicles such as BCRED. Per the publisher's data, analysts over the past month rated the stock Buy on average, with a price target averaging $142.67 (range $116.00 to $188.00).
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.